- Report of Foreign Issuer (6-K)
26 3월 2011 - 5:09AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2011
Commission File Number: 001-33340
TONGJITANG CHINESE MEDICINES COMPANY
5th Floor, Block B
Nanshan Medical Device Park
1019 Nanhai Avenue, Shekou, Nanshan District
Shenzhen, 518067 Guangdong Province
People’s Republic of China
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under the cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Enclosure: Press release, dated March 25, 2011, regarding Tongjitang’s fourth quarter and full year 2010 financial results
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
Tongjitang Chinese Medicines Company
|
|
|
By:
|
/s/ Justin Chen
|
|
|
|
Name:
|
Justin Chen
|
|
|
|
Title:
|
Director, Chief Operating Officer and
Interim Chief Financial Officer
|
|
|
Date: March 25, 2011
EXHIBIT INDEX
Exhibit No.
|
|
|
99.1
|
|
Press release, dated March 25, 2011, regarding Tongjitang’s fourth quarter and full year 2010 financial results
|
-3-
Tycom Ltd (NYSE:TCM)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Tycom Ltd (NYSE:TCM)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024